News from the FDA: Drug Development in the Age of Targeted Therapy
Back to the Agenda |
Tuesday, December 14, 2010
11:30 am - 2:15 pm
This panel will discuss how advances in science and technology, including genomics, offer exciting new opportunities to transform the drug development and review process. They will address how academia, companies, and FDA can speed the development of targeted treatments for cancer and other devastating illnesses, including innovative trial designs and regulatory policies. |
| |
| Speakers: |
 |
| • |
Margaret Hamburg, M.D.
Commissioner
U.S. Food and Drug Administration
|
|
| • |
Janet Woodcock, M.D.
Director of the Center for Drug Evaluation and Research
U.S. Food and Drug Administration
|
|
|
| |
 |
 |
|
|
Terms Of Use // Privacy Statement
© 2010 by Partnering for Cures |
 |
 |
 |
 |
|
